Submit Deal

ARTIS VENTURES

HQ - San Francisco

Summary

ARTIS Ventures is a financial services firm that finances early-to-late stage venture investments.

Deals Overview

Total Deals8

Valued Deals8

Total Value£ 735 M

Avg. Deal Size£ 92 M

Market Context

Senior Management

Vasudev Bailey
Senior Partner
Stuart Peterson
Managing General Partner

Sort

excision biotherapeutics

HQ - United States

Pharmaceuticals

17 Feb 2021

Investment Date

£ 43 M

Deal Value

cerebral

HQ - United States

Health Care Services

8 Dec 2021

Investment Date

Stake

£ 226 M

Deal Value

tessera therapeutics

HQ - United States

Biotechnology

19 Apr 2022

Investment Date

£ 230 M

Deal Value

oni biotechnology

HQ - United Kingdom

Biotechnology

20 Jan 2022

Investment Date

£ 61 M

Deal Value

affect therapeutics

HQ - United States

Health Care Services

12 Jul 2023

Investment Date

£ 12 M

Deal Value

replay holdings

HQ - United Kingdom,United States

Pharmaceuticals

Biotechnology

25 Jul 2022

Investment Date

£ 45 M

Deal Value

unnatural products

HQ - United States

Biotechnology

19 Dec 2023

Investment Date

£ 25 M

Deal Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy